Traders work on the floor of the New York Stock Exchange.
NYSE
(This story is for CNBC Pro subscribers only).
Positive news about Covid-19 vaccine candidates has helped fuel a rally in reopening plays in recent weeks, but some names are still undervalued, according to Barclays.
The firm combed through its basket of stocks where Covid-19 had been a short-term negative and identified the names where valuations are the lowest relative to recent history. Barclays said in a note that these beaten-down names “could outperform in an economic recovery as things normalize.”
